Primary care prescribing data for drugs to treat obesity
In the UK, it is estimated that 1 in 4 adults are obese. For patients who meet certain criteria, adjunctive therapies are available on prescription, these include lipase inhibitors and glucagon-like-peptides (GLP-1). All prescribing data for these therapies is collated in GPrX Data’s quality assured dataset and is available via any of our solutions: Online, Enterprise or as a custom query. For more information about our offerings please see our Solutions pages.
For a prescribing data snapshot for the obesity sector, please see the RxIndex to the right.
More on obesity from GPrX
Sector specific resources for the obesity market coming soon!